Free Trial

PACS Group, Inc. (NYSE:PACS) Short Interest Down 21.6% in February

PACS Group logo with Medical background
Remove Ads

PACS Group, Inc. (NYSE:PACS - Get Free Report) saw a significant decline in short interest in February. As of February 15th, there was short interest totalling 2,730,000 shares, a decline of 21.6% from the January 31st total of 3,480,000 shares. Based on an average daily volume of 750,000 shares, the days-to-cover ratio is currently 3.6 days. Currently, 7.1% of the shares of the stock are sold short.

Analyst Ratings Changes

A number of analysts have recently weighed in on PACS shares. Macquarie lowered their target price on PACS Group from $42.00 to $24.00 and set an "outperform" rating for the company in a research note on Monday, January 6th. Stephens lowered their price objective on shares of PACS Group from $48.00 to $31.00 and set an "overweight" rating for the company in a research report on Monday, November 18th. Truist Financial reduced their target price on shares of PACS Group from $46.00 to $32.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and issued a $18.00 price target on shares of PACS Group in a report on Tuesday, December 17th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, PACS Group presently has a consensus rating of "Moderate Buy" and an average target price of $34.00.

View Our Latest Stock Report on PACS

PACS Group Price Performance

Shares of NYSE:PACS traded down $0.12 during trading on Friday, hitting $12.95. 376,740 shares of the company's stock were exchanged, compared to its average volume of 538,746. The firm has a 50-day moving average price of $13.58 and a two-hundred day moving average price of $24.43. PACS Group has a 1-year low of $12.38 and a 1-year high of $43.92. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.82.

Remove Ads

Institutional Trading of PACS Group

A number of institutional investors have recently bought and sold shares of PACS. Barclays PLC grew its position in shares of PACS Group by 651.3% during the 3rd quarter. Barclays PLC now owns 63,366 shares of the company's stock worth $2,532,000 after buying an additional 54,932 shares during the period. Lisanti Capital Growth LLC bought a new position in shares of PACS Group during the third quarter worth $4,259,000. Concentric Capital Strategies LP acquired a new position in shares of PACS Group in the 3rd quarter valued at $3,970,000. Maven Securities LTD bought a new stake in shares of PACS Group in the 3rd quarter valued at $3,997,000. Finally, Wellington Management Group LLP raised its stake in PACS Group by 60.5% during the 3rd quarter. Wellington Management Group LLP now owns 5,376,551 shares of the company's stock worth $214,901,000 after buying an additional 2,025,835 shares during the period.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Read More

Should You Invest $1,000 in PACS Group Right Now?

Before you consider PACS Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.

While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!
Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads